These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11295984)

  • 1. One-stop shopping: stroke questions further answered with magnetic resonance imaging.
    Levine RL
    Arch Neurol; 2001 Apr; 58(4):555-6. PubMed ID: 11295984
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging.
    Tong DC; Adami A; Moseley ME; Marks MP
    Arch Neurol; 2001 Apr; 58(4):587-93. PubMed ID: 11295989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid resorption of intraventricular hemorrhage after thrombolytic therapy of ischemic stroke.
    Szabo K; Sommer A; Gass A; Hennerici M
    Cerebrovasc Dis; 2001 Aug; 12(2):144. PubMed ID: 11490110
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
    Grotta J;
    Cerebrovasc Dis; 2001; 12(3):258-63. PubMed ID: 11641593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.
    Caplan LR; Mohr JP; Kistler JP; Koroshetz W
    N Engl J Med; 1997 Oct; 337(18):1309-10; discussion 1313. PubMed ID: 9345084
    [No Abstract]   [Full Text] [Related]  

  • 6. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight.
    Haley EC; Lewandowski C; Tilley BC
    Ann Emerg Med; 1997 Nov; 30(5):676-82. PubMed ID: 9360581
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients.
    Grotta J
    N Engl J Med; 1997 Oct; 337(18):1310-3. PubMed ID: 9345085
    [No Abstract]   [Full Text] [Related]  

  • 9. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of reteplase with alteplase for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
    N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-PA: the SEDAN score.
    Brüning T; Al-Khaled M
    CNS Neurosci Ther; 2015 Mar; 21(3):296-7. PubMed ID: 25622691
    [No Abstract]   [Full Text] [Related]  

  • 12. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolysis for stroke.
    Brott T
    Arch Neurol; 1996 Dec; 53(12):1305-6. PubMed ID: 8970461
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke.
    Moriya Y; Takahashi W; Kijima C; Yutani S; Iijima E; Mizuma A; Honma K; Uesugi T; Ohnuki Y; Nagata E; Yanagimachi N; Takizawa S
    Tokai J Exp Clin Med; 2013 Apr; 38(1):24-7. PubMed ID: 23564572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should a hospital without a neurologist use t-PA to treat stroke?
    Krieger DW
    Cleve Clin J Med; 1999; 66(10):585-6. PubMed ID: 10598361
    [No Abstract]   [Full Text] [Related]  

  • 16. Rupture of a thoracic aortic aneurysm: a rare adverse reaction following systemic tissue plasminogen activator infusion.
    Hayashi H; Kawamata H; Ichikawa K; Tajima H; Kumazaki T
    Heart Vessels; 2004 Jul; 19(4):208-11. PubMed ID: 15278397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.
    Prats-Sánchez L; Camps-Renom P; Sotoca-Fernández J; Delgado-Mederos R; Martínez-Domeño A; Marín R; Almendrote M; Dorado L; Gomis M; Codas J; Llull L; Gómez González A; Roquer J; Purroy F; Gómez-Choco M; Cánovas D; Cocho D; Garces M; Abilleira S; Martí-Fàbregas J;
    Stroke; 2016 Aug; 47(8):2003-9. PubMed ID: 27406103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerated dosing regimen.
    Coplin WM; Broderick J; Tomsick TT
    Neurosurgery; 2001 Jul; 49(1):228-9. PubMed ID: 11440452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.